Platelet RNA modules point to coronary calcification in asymptomatic women with former preeclampsia

Robin J G Hartman1, Suzanne J A Korporaal1, Michal Mokry2

  • 1Laboratory of Experimental Cardiology, UMC Utrecht, Utrecht University, Utrecht, the Netherlands.

Atherosclerosis
|November 10, 2019
PubMed

Insights

Platelet RNA modules correlate with cardiovascular risk in women with a history of preeclampsia. These findings highlight platelets as potential biomarkers for cardiovascular disease risk assessment.

Area of Science:

  • Cardiovascular Disease Research
  • Platelet Biology
  • Genomics and Transcriptomics

Background:

  • Preeclampsia significantly increases women's risk of developing cardiovascular disease later in life.
  • Platelets are known to be affected by preeclampsia, suggesting they may hold clues to future cardiovascular health.

Purpose of the Study:

  • To investigate if platelet transcriptomes can predict cardiovascular risk in women with a history of preeclampsia.
  • To identify specific platelet gene expression patterns associated with cardiovascular risk factors.

Main Methods:

  • Isolated platelets from asymptomatic women with prior preeclampsia who underwent coronary computed tomography angiography.
  • Constructed gene networks from platelet RNA using an unbiased approach.
  • Correlated platelet gene modules with clinical traits, including coronary artery calcium scores (CACS).

Main Results:

  • Identified multiple platelet gene modules significantly correlated with CACS (correlation coefficients 0.44 to 0.59).
  • Two key modules showed higher gene expression in women with calcifications and were enriched for platelet activation pathways.
  • One module was also enriched for genes associated with coronary artery disease susceptibility loci.

Conclusions:

  • Platelet RNA modules correlate with coronary artery calcification in women with prior preeclampsia.
  • These findings suggest platelet transcriptomes may serve as biomarkers for cardiovascular risk.
  • Further research is needed to determine if platelets directly contribute to or merely reflect cardiovascular disease progression.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
346
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
325
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
829
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
269
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
280